Financials data is unavailable for this security.
View more
Year on year Rossari Biotech Ltd grew revenues 10.55% from 16.56bn to 18.31bn while net income improved 21.85% from 1.07bn to 1.31bn.
| Gross margin | 29.57% |
|---|---|
| Net profit margin | 7.14% |
| Operating margin | 10.22% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, cash reserves at Rossari Biotech Ltd fell by 440.28m. However, the company earned 432.55m from its operations for a Cash Flow Margin of 2.36%. In addition the company generated 161.85m cash from financing while 1.03bn was spent on investing.
| Cash flow per share | 35.77 |
|---|---|
| Price/Cash flow per share | 25.54 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 21.91%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.05% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 2.03% |
| EPS growth(5 years) | 21.28 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 26.54 |
More ▼
